Xofigo
| Xofigo | |
|---|---|
| Term | Xofigo |
| Short definition | Xofigo - (pronounced) (SOH-fee-goh) radioactive drug used to treat prostate cancer that has spread to the bone and is causing symptoms but has not spread to other organs. It is used in patients whose cancer is resistant to castration (has not responded to treatments to lower testosterone levels). |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Xofigo - (pronounced) (SOH-fee-goh) radioactive drug used to treat prostate cancer that has spread to the bone and is causing symptoms but has not spread to other organs. It is used in patients whose cancer is resistant to castration (has not responded to treatments to lower testosterone levels). It is also being studied in the treatment of other types of cancer. Xofigo contains a radioactive substance called radium Ra 223. It builds up in bone and gives off radiation that can kill cancer cells. Xofigo is a type of radiation therapy drug. Also called radium Ra 223 dichloride
External links
- Medical encyclopedia article on Xofigo
- Wikipedia's article - Xofigo
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski